Oral antenatal corticosteroids evaluated in fetal sheep
Schmidt, A.F., Jobe, A.H., Kannan, P.S., Bridges, J.P., Newnham, J.P., Saito, M., Usuda, H., Kumagai, Y., Fee, E.L., Clarke, M. and Kemp, M.W. (2019) Oral antenatal corticosteroids evaluated in fetal sheep. Pediatric Research, 86 .
*No subscription required
Abstract
Background: The use of antenatal corticosteroids (ACS) in low-resource environments is sporadic. Further, drug choice, dose, and route of ACS are not optimized. We report the pharmacokinetics and pharmacodynamics of oral dosing of ACS using a preterm sheep model.
Methods: We measured pharmacokinetics of oral betamethasone-phosphate (Beta-P) and dexamethasone-phosphate (Dex-P) using catheterized pregnant sheep. We compared fetal lung maturation responses of oral Beta-P and Dex-P to the standard treatment with 2 doses of the i.m. mixture of Beta-P and betamethasone-acetate at 2, 5, and 7 days after initiation of ACS. Results: Oral Dex-P had lower bioavailability than Beta-P, giving a lower maximum maternal and fetal concentration. A single oral dose of 0.33 mg/kg of Beta-P was equivalent to the standard clinical treatment assessed at 2 days; 2 doses of 0.16 mg/kg of oral Beta-P were equivalent to the standard clinical treatment at 7 days as assessed by lung mechanics and gas exchange after preterm delivery and ventilation. In contrast, oral Dex-P was ineffective because of its decreased bioavailability.
Conclusion: Using a sheep model, we demonstrate the use of pharmacokinetics to develop oral dosing strategies for ACS. Oral dosing is feasible and may facilitate access to ACS in low-resource environments
Item Type: | Journal Article |
---|---|
Murdoch Affiliation(s): | School of Veterinary and Life Sciences |
Publisher: | Nature Publishing Group |
Copyright: | © 2019, The Author(s) |
URI: | http://researchrepository.murdoch.edu.au/id/eprint/52596 |
![]() |
Item Control Page |
Downloads
Downloads per month over past year